Optimization of the Interligand Overhauser Effect for Fragment Linking: Application to Inhibitor Discovery against Mycobacterium tuberculosis Pantothenate Synthetase
about
Process of Fragment-Based Lead Discovery-A Perspective from NMRIntegrated biophysical approach to fragment screening and validation for fragment-based lead discoveryHigh-Throughput Interrogation of Ligand Binding Mode Using a Fluorescence-Based AssayNMR approaches in structure-based lead discovery: recent developments and new frontiers for targeting multi-protein complexesNMR-based analysis of protein-ligand interactions.Overview of Probing Protein-Ligand Interactions Using NMR.Fragment-based drug discovery using NMR spectroscopyA three-stage biophysical screening cascade for fragment-based drug discovery.In-silico Metabolome Target Analysis Towards PanC-based Antimycobacterial Agent Discovery.Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology.Compound Design by Fragment-Linking.Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency AnalysisA comparison of the dynamics of pantothenate synthetase from M. tuberculosis and E. coli: computational studies.Hit Generation in TB Drug Discovery: From Genome to Granuloma.Impact of a Central Scaffold on the Binding Affinity of Fragment Pairs Isolated from DNA-Encoded Self-Assembling Chemical Libraries.Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis
P2860
Q26738768-3343D176-8966-4CCE-84E0-A3C4496B867DQ27679154-170AEDBE-FC53-4031-BF61-9BEDEE223AEEQ27681364-CE357A35-8DDE-4878-866C-3CB75A7BD5B4Q30366295-AF628682-1C17-40F4-892C-7CF1D11552E6Q30617417-00684BD0-CFDB-4AD7-9F5E-07976FA8B299Q30984731-56479676-968C-40D9-A77D-0CB58AC1E3D0Q34345451-1F74E74E-D30D-4563-94B5-7417230DC89DQ35025905-40593C35-8890-41CB-9DF4-A95A5646CC63Q35538689-D18C0432-0E20-4164-827D-2F3BBADCB4A1Q36341852-00E4673A-FD1B-47CA-84F3-B4E9E40679BFQ38061197-04A009A4-9A5E-4B89-BF08-1773560509E3Q38910944-A4E0483A-556B-443D-A873-6E633189D47FQ42414411-C321278F-CFA3-42A3-899B-CD36DE02DC42Q45786244-BC183543-F590-4708-B004-414C14A0CDC1Q47702665-D8DEAACF-A4BD-456A-9B52-BEF9BB64AA82Q47750102-8CE9EB6A-586D-476F-AAE9-2ABD8E9272B4Q58860051-B45E3B03-8CC3-416A-9EB4-B1054FBB259E
P2860
Optimization of the Interligand Overhauser Effect for Fragment Linking: Application to Inhibitor Discovery against Mycobacterium tuberculosis Pantothenate Synthetase
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@ast
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@en
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@nl
type
label
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@ast
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@en
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@nl
prefLabel
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@ast
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@en
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@nl
P2093
P2860
P50
P356
P1476
Optimization of the Interligan ...... ulosis Pantothenate Synthetase
@en
P2093
Alvin W Hung
H Leonardo Silvestre
Pawel Sledz
P2860
P304
P356
10.1021/JA100595U
P407
P577
2010-04-07T00:00:00Z